Standard BioTools CEO reports equity compensation moves
STANDARD BIOTOOLS INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
STANDARD BIOTOOLS INC. President & CEO Michael Egholm reported equity compensation activity and related tax withholding transactions. On April 6, 2026, 196,513 restricted stock units converted into the same number of common shares, and 95,014 of those shares were withheld at $0.908 per share to cover tax obligations. Following these events, he directly held 6,695,582 common shares. On March 20, 2026, he also received a grant of 2,345,340 stock options with a $0.9846 exercise price, expiring in 2036, and a separate award of 1,042,373 shares of common stock; both vest in installments over four years.
Insider Trade Summary
196,513 shares exercised/converted
Exercise
5 txns
Insider
Egholm Michael
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 196,513 | $0.00 | $0.00 |
| Exercise | Common Stock | 196,513 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 95,014 | $0.908 | $86K |
| Grant/Award | Stock Option (Right to buy) | 2,345,340 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,042,373 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to buy) — 2,345,340 contracts (Direct);
Restricted Stock Units — 0 contracts (Direct);
Common Stock — 6,695,582 shares (Direct)
Footnotes (5)
- F1. Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
- F2. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of RSUs granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022.
- F3. The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
- F4. Each RSU represents the contingent right to receive one share of the Issuer's common stock.
- F5. On April 4, 2022, the Reporting Person was granted 786,049 RSUs, vesting in four equal annual installments beginning on April 4, 2023.
Key Figures
RSUs converted: 196,513 shares
Shares withheld for taxes: 95,014 shares at $0.908
Post-transaction holdings: 6,695,582 shares
+3 more
6 metrics
RSUs converted
196,513 shares
RSUs vesting into common stock on April 6, 2026
Shares withheld for taxes
95,014 shares at $0.908
Tax withholding on RSU vesting, April 6, 2026
Post-transaction holdings
6,695,582 shares
Common stock directly held after April 6, 2026
Stock options granted
2,345,340 options at $0.9846
Option grant on March 20, 2026, expiring March 20, 2036
Common stock grant
1,042,373 shares
Awarded on March 20, 2026 as equity compensation
Prior RSU grant
786,049 RSUs
Granted April 4, 2022, vesting in four annual installments
Key Terms
Restricted Stock Units, tax withholding obligations, Stock Option (Right to buy), exercise price, +1 more
5 terms
Restricted Stock Units financial
"Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of RSUs"
Stock Option (Right to buy) financial
"Stock Option (Right to buy) with an exercise price of 0.9846 and expiration date in 2036"
exercise price financial
"The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did STANDARD BIOTOOLS (LAB) CEO Michael Egholm report?
Michael Egholm reported RSU vesting into 196,513 common shares, related tax withholding of 95,014 shares at $0.908, a grant of 2,345,340 stock options at a $0.9846 exercise price, and an award of 1,042,373 common shares, all as part of equity compensation.
What were the details of the new stock option grant to the STANDARD BIOTOOLS (LAB) CEO?
Michael Egholm received 2,345,340 stock options with a $0.9846 exercise price, expiring on March 20, 2036. The option becomes exercisable as to one-sixteenth of the shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter.
How were taxes handled on the STANDARD BIOTOOLS (LAB) CEO’s RSU vesting?
When 196,513 RSUs vested on April 6, 2026, 95,014 resulting common shares were withheld at $0.908 per share to satisfy tax withholding obligations. This tax-withholding disposition was not an open-market sale but a share reduction to cover associated tax liabilities.
What RSU awards did the STANDARD BIOTOOLS (LAB) CEO receive in this period?
The filing shows 196,513 RSUs converting into common shares on April 6, 2026, and notes a prior 786,049-RSU grant from April 4, 2022. Additionally, Egholm received a new award of 1,042,373 common shares, which vest over four years in scheduled installments.
Over what schedule do the CEO’s new STANDARD BIOTOOLS (LAB) equity awards vest?
The 2,345,340 stock options vest with one-sixteenth of the underlying shares becoming exercisable on May 20, 2026, and the remainder vesting in equal quarterly installments. The new 1,042,373-share award and certain RSUs similarly vest over four years, conditioned on continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
